0.05Open0.05Pre Close0 Volume4 Open Interest1.00Strike Price0.00Turnover90.16%IV14.41%PremiumJan 17, 2025Expiry Date0.00Intrinsic Value100Multiplier23DDays to Expiry0.05Extrinsic Value100Contract SizeAmericanOptions Type-0.2804Delta1.3252Gamma22.20Leverage Ratio-0.0018Theta-0.0002Rho-6.23Eff Leverage0.0010Vega
TherapeuticsMD Stock Discussion
The company also released its Q3 financial report, posting a net loss from continuing operations of $0.13 per share...
• $AmerisourceBergen (ABC.US)$ : Deutsche Bank Upgrades to Buy from Hold - PT $178 (from $167)
• $Arch Resources (ARCH.US)$ : Jefferies Upgrades to Buy From Hold - PT $225 (from $160)
• $BHP Group Ltd (BHP.US)$ : Jefferies Upgrades to Buy From Hold - PT $82 (from $72)
• $Peabody Energy (BTU.US)$ : Jefferies Upgrades to Buy From Hold - PT $36 (from $25)
• $Warrior Met Coal (HCC.US)$ : Jefferies Upgrades to Buy From Hold - PT $50 (from $36)
• $Liberty Global-A (LBTYA.US)$ : Berenbe...
• $Boot Barn Holdings (BOOT.US)$ : Piper Sandler Upgrades to Overweight from Neutral - PT $121 (from $109)
• $EPAM Systems (EPAM.US)$ : BofA Securities Upgrades to Buy from Neutral - PT $400 (from $312)
• $Hersha Hospitality Trust (HT.US)$ : Stifel Upgrades to Buy from Hold - PT $14.50 (from $11)
• $Jounce Therapeutics (JNCE.US)$ : Raymond James Upgrades to Strong Buy from Outperform - PT $20 (from $15)
• $Pactiv Evergreen (PTVE.US)$ : RBC Capital Upgra...
No comment yet